Prostatic hyperplasia, also known as “benign prostatic hyperplasia”, is one of the most common benign diseases that cause urinary disorders in middle-aged and older men.
According to statistics, about half of all men over the age of 60 will exhibit symptoms of prostate enlargement. In the case of men over 80 years old, about 80% of them will show symptoms of prostate enlargement. This shows that middle-aged and older men are prone to prostate enlargement.
After suffering from prostate enlargement, male patients will experience symptoms such as frequent urination, urgent urination, increased nocturnal urination, waiting to urinate, and difficulty in urination. The actual fact is that you will find a lot of people who are not able to get a good deal on this. The actual fact is that you will find a lot of people who think that the treatment of prostate enlargement can only be surgical, and that taking medicine is not useful at all. In fact, this is not the case.
The actual fact is, the treatment is based on watchful waiting, medication as well as surgical treatment, medication for prostate enlargement is dependable. The actual fact is that you can find a lot of people who are not able to get a good deal on the actual situation.
Generally speaking, the short-term goal of medication for patients with prostate enlargement is to relieve the patient’s lower urinary tract symptoms, and the long-term goal is to slow down the clinical progression of the disease. Next, the common medications used to treat prostate enlargement are introduced.
Alpha-blockers
Alpha-blockers are indicated for patients with prostatic hyperplasia who have lower urinary tract symptoms. Commonly used alpha-blockers include tamsulosin, doxazosin, alfuzosin and terazosin.
5-alpha reductase inhibitors
5-alpha reductase inhibitors are indicated for the treatment of patients with enlarged prostate volume with lower urinary tract symptoms. Commonly used 5-alpha reductase inhibitors include finasteride and dutasteride.
Combination therapy
Combination therapy, i.e. combination of alpha-blockers and 5-alpha reductase inhibitors for prostate enlargement, is indicated for prostate enlargement with enlarged prostate volume and lower urinary tract symptoms.
